Company registration number 09803066 (England and Wales)
ASTUTE ORTHOPAEDIC SOLUTIONS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
ASTUTE ORTHOPAEDIC SOLUTIONS LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
ASTUTE ORTHOPAEDIC SOLUTIONS LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2025
31 October 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
16,423
-
0
Tangible assets
4
36,380
46,967
Investments
5
208,000
93,100
260,803
140,067
Current assets
Debtors
6
11,198
-
0
Cash at bank and in hand
564,628
617,368
575,826
617,368
Creditors: amounts falling due within one year
7
(103,697)
(100,848)
Net current assets
472,129
516,520
Net assets
732,932
656,587
Capital and reserves
Called up share capital
140
140
Profit and loss reserves
732,792
656,447
Total equity
732,932
656,587

For the financial year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 15 July 2026 and are signed on its behalf by:
Dr S S Mehta
Director
Company registration number 09803066 (England and Wales)
ASTUTE ORTHOPAEDIC SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
- 2 -
1
Accounting policies
1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.true

1.3
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
15% reducing balance
Computers
25% on cost
Motor vehicles
25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

ASTUTE ORTHOPAEDIC SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
- 3 -
1.6
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.11
Company information

Astute Orthopaedic Solutions Limited is a private company limited by shares incorporated in England and Wales. The registered office is 202 Seabridge Lane, Newcastle, ST5 3LS.

ASTUTE ORTHOPAEDIC SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 4 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
3
Intangible fixed assets
Crypto Investments
£
Cost
At 1 November 2024
-
0
Additions
16,423
At 31 October 2025
16,423
Amortisation and impairment
At 1 November 2024 and 31 October 2025
-
0
Carrying amount
At 31 October 2025
16,423
At 31 October 2024
-
0
4
Tangible fixed assets
Plant and equipment
Computers
Motor vehicles
Total
£
£
£
£
Cost
At 1 November 2024 and 31 October 2025
18,246
6,587
56,990
81,823
Depreciation and impairment
At 1 November 2024
5,335
3,253
26,268
34,856
Depreciation charged in the year
1,937
970
7,680
10,587
At 31 October 2025
7,272
4,223
33,948
45,443
Carrying amount
At 31 October 2025
10,974
2,364
23,042
36,380
At 31 October 2024
12,911
3,334
30,722
46,967
ASTUTE ORTHOPAEDIC SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 5 -
5
Fixed asset investments
2025
2024
£
£
Other investments other than loans
208,000
93,100
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 November 2024
93,100
Additions
114,900
At 31 October 2025
208,000
Carrying amount
At 31 October 2025
208,000
At 31 October 2024
93,100
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
11,198
-
0
7
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
56,183
51,402
Other creditors
47,514
49,446
103,697
100,848
8
Financial commitments, guarantees and contingent liabilities

The director's are not aware of any contingent liabilities.

 

9
Events after the reporting date

There have been no significant post balance sheet events.

 

2025-10-312024-11-01falsefalsefalse16 July 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityDr S S MehtaDr S Gaba098030662024-11-012025-10-31098030662025-10-31098030662024-10-3109803066core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2025-10-3109803066core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-10-3109803066core:PlantMachinery2025-10-3109803066core:ComputerEquipment2025-10-3109803066core:MotorVehicles2025-10-3109803066core:PlantMachinery2024-10-3109803066core:ComputerEquipment2024-10-3109803066core:MotorVehicles2024-10-3109803066core:WithinOneYear2025-10-3109803066core:WithinOneYear2024-10-3109803066core:CurrentFinancialInstruments2025-10-3109803066core:CurrentFinancialInstruments2024-10-3109803066core:ShareCapital2025-10-3109803066core:ShareCapital2024-10-3109803066core:RetainedEarningsAccumulatedLosses2025-10-3109803066core:RetainedEarningsAccumulatedLosses2024-10-3109803066bus:Director12024-11-012025-10-3109803066core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3109803066core:PlantMachinery2024-11-012025-10-3109803066core:ComputerEquipment2024-11-012025-10-3109803066core:MotorVehicles2024-11-012025-10-31098030662023-11-012024-10-3109803066core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-10-3109803066core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-11-012025-10-3109803066core:PlantMachinery2024-10-3109803066core:ComputerEquipment2024-10-3109803066core:MotorVehicles2024-10-31098030662024-10-3109803066core:CurrentFinancialInstrumentscore:WithinOneYear2025-10-3109803066core:CurrentFinancialInstrumentscore:WithinOneYear2024-10-3109803066bus:PrivateLimitedCompanyLtd2024-11-012025-10-3109803066bus:SmallCompaniesRegimeForAccounts2024-11-012025-10-3109803066bus:FRS1022024-11-012025-10-3109803066bus:AuditExemptWithAccountantsReport2024-11-012025-10-3109803066bus:Director22024-11-012025-10-3109803066bus:FullAccounts2024-11-012025-10-31xbrli:purexbrli:sharesiso4217:GBP